MXCT
MaxCyte Inc

448
Mkt Cap
$73.05M
Volume
1.07M
52W High
$2.96
52W Low
$0.6434
PE Ratio
-1.63
MXCT Fundamentals
Price
$0.6836
Prev Close
$0.7168
Open
$0.6981
50D MA
$0.8522
Beta
1.37
Avg. Volume
1.51M
EPS (Annual)
-$0.4194
P/B
0.43
Rev/Employee
$362,923.08
$79.86
Loading...
Loading...
News
all
press releases
MaxCyte, Inc. (NASDAQ:MXCT) Receives Average Rating of "Hold" from Brokerages
MaxCyte, Inc. (NASDAQ:MXCT - Get Free Report) has been assigned an average rating of "Hold" from the five ratings firms that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, two have given a hold recommendation and two...
MarketBeat·23h ago
News Placeholder
More News
News Placeholder
Craig Hallum Issues Pessimistic Forecast for MaxCyte (NASDAQ:MXCT) Stock Price
Craig Hallum reduced their target price on MaxCyte from $7.00 to $5.00 and set a "buy" rating for the company in a research note on Wednesday...
MarketBeat·3d ago
News Placeholder
MaxCyte (MXCT) Q4 2025 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets·3d ago
News Placeholder
MaxCyte Q4 Earnings Call Highlights
MaxCyte (NASDAQ:MXCT) executives told investors the company made meaningful progress in 2025 despite a difficult operating environment, highlighting continued strategic platform license (SPL...
MarketBeat·3d ago
News Placeholder
MaxCyte, Inc. (MXCT) Reports Q4 Loss, Misses Revenue Estimates
MaxCyte (MXCT) delivered earnings and revenue surprises of +25.00% and -17.98%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3d ago
News Placeholder
MaxCyte (NASDAQ:MXCT) Issues Earnings Results
MaxCyte (NASDAQ:MXCT - Get Free Report) released its earnings results on Tuesday. The company reported ($0.09) earnings per share for the quarter, missing analysts' consensus estimates of ($0.08) by...
MarketBeat·4d ago
News Placeholder
MaxCyte (NASDAQ:MXCT) Rating Lowered to "Sell" at Wall Street Zen
Wall Street Zen lowered MaxCyte from a "hold" rating to a "sell" rating in a research report on Monday...
MarketBeat·5d ago
News Placeholder
MaxCyte, Inc. $MXCT Shares Bought by Mirabella Financial Services LLP
Mirabella Financial Services LLP grew its holdings in MaxCyte, Inc. (NASDAQ:MXCT - Free Report) by 24.2% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 8,200,000 shares of the company's stock aft...
MarketBeat·9d ago
News Placeholder
Mirabella Financial Services LLP Purchases 1,600,000 Shares of MaxCyte, Inc. $MXCT
Mirabella Financial Services LLP lifted its holdings in MaxCyte, Inc. (NASDAQ:MXCT - Free Report) by 24.2% during the third quarter, according to its most recent 13F filing with the Securities...
MarketBeat·11d ago
News Placeholder
MaxCyte (MXCT) Projected to Post Earnings on Tuesday
MaxCyte (NASDAQ:MXCT) will be releasing its Q4 2025 earnings after the market closes on Tuesday, March 24. (View Earnings Report at...
MarketBeat·11d ago
<
1
2
...
>

Latest MXCT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.